(NASDAQ: FEED) Just Landed on Our Watchlist With Less Than 6.1M Shares Listed As Available to the Public

Any content you receive is for information purposes only. Always conduct your own research. *Sponsored ENvue Medical, Inc. (NASDAQ: FEED) Just Hit The Top Of Our Watchlist This Morning—Thursday, July 9, 2026 Don’t Miss Our Next Update—Get Real-Time Alerts Sent Directly To Your Phone. Up To 10X Faster Than Email. Get FEED Up On The Screen While It’s Still Early… July 9, 2026 Dear Reader, Sometimes the biggest developments don't arrive all at once. They begin connecting one after another until the broader story starts coming into focus. That's exactly what has happened over the past several weeks, and it's one of the reasons this company has climbed near the top of our watchlist. And that is exactly why ENvue Medical, Inc. (NASDAQ: FEED) just landed on our radar this morning—Thursday, July 9, 2026. But keep in mind, FEED has less than 6.1M shares listed as available to the public right now. When companies have small floats like this, the potential exists for big moves if demand begins to shift. FEED appears to be flying under the radar as it’s currently trending in the $.50 - $.60 range and was well above the $1 mark less than two months ago, according to data available from Barchart. That setup alone would be enough to get our attention, but the recent news flow is where the story starts to become even more interesting. On June 9, 2026, ENvue Medical, Inc. introduced "Ask Oscar™," an AI-powered training platform designed to lower one of the most persistent barriers in medical device adoption: clinician training. The platform builds on the company's existing electromagnetic navigation infrastructure, enabling nurses and dietitians to train independently—without requiring on-site specialists—and is expected to be commercially available within coming months, opening a new recurring revenue stream across ENvue's growing hospital customer base. The timing was not accidental. Just days earlier, on June 3, an independent peer-reviewed study published in Critical Care Nurse documented what ENvue's technology accomplished across 531 consecutive feeding tube placements at Inova Health System: zero lung placements across 531 consecutive placements, a 67% reduction in ventilator-associated pneumonia, a dramatic increase in bedside post-pyloric feeding access that previously required interventional radiology, more than 350 nursing hours recovered annually, and over $1.5M in annual cost avoidance. Numbers like those, independently verified and published in a peer-reviewed journal, represent the kind of clinical validation that institutional buyers require before standardizing a technology. Against that clinical backdrop, ENvue now counts 40+ U.S. hospitals in its installed base, a secured three-year purchasing agreement renewal with a GPO representing one of the largest health systems in the country operating over 90 hospitals, and a commercial pipeline that management has described as actively converting. The company's revenue model is platform-based and designed for compounding growth. Each ENvue Navigation System placed in a hospital requires proprietary single-use consumable feeding tubes unique to the platform, meaning every procedure performed on the installed hardware drives downstream recurring revenue. As the hospital footprint scales, that consumable layer grows with it—without proportional increases in customer acquisition cost. For a company at ENvue's current stage of commercial development, that dynamic is worth understanding. What is emerging here is a medtech story centered on replacing an 85-year-old clinical standard. According to ENvue's own market analysis, more than 13M nasoenteral feeding tube placements occur in U.S. hospitals each year, and 85% are performed blindly—without any real-time visual guidance. The ENvue Navigation Platform addresses that gap directly, providing continuous electromagnetic visualization of tube position throughout the procedure, reducing reliance on post-placement X-ray confirmation and the associated radiology bottlenecks, staffing pressures, and complication risk that hospitals are under increasing pressure to eliminate. About ENvue Medical, Inc. (NASDAQ: FEED) FEED is a commercial-stage medical device company headquartered in Tyler, Texas, with research and development operations in Tel-Aviv and Nesher, Israel, and commercial operations in Arlington Heights, Illinois. The company was formerly known as NanoVibronix, Inc., rebranding in December 2025 following the acquisition of ENvue Medical Holdings to reflect its primary strategic focus on the ENvue Navigation Platform. ENvue operates two distinct technology platforms. The ENvue Navigation Platform is a minimally invasive electromagnetic navigation system cleared by the FDA under 510(k) for adult use, providing real-time bedside visualization of tube movement through three simultaneous views with automated alerts when a feeding tube approaches the airway. The second platform comprises acoustic-based therapeutic devices—PainShield®, a patch-based therapeutic ultrasound device for pain management and joint contractures, and UroShield®, designed to reduce bacterial colonization and biofilm in urinary catheters. UroShield was recently added to the UK National Health Service Drug Tariff Part IX, enabling nationwide prescription reimbursement in the UK. Revenue is generated through a platform model. Hospitals acquire the ENvue Navigation System and subsequently consume single-use proprietary feeding tubes on a per-procedure basis, creating predictable, recurring revenue tied directly to clinical utilization. In January 2026, ENvue expanded beyond the acute care setting with the launch of its ENFit Syringe line for over-the-counter distribution through a strategic partnership with U-Deliver, extending the ENvue brand into home care and non-acute settings. A $8B Market Is Quietly Replacing an 85-Year-Old Clinical Standard ENvue Medical operates within the global enteral feeding devices market, a sector undergoing structurally supported expansion. According to Precedence Research, the global enteral feeding devices market was valued at $4.96B in 2025 and is projected to reach $8.02B by 2035, representing a compound annual growth rate of 4.92% over the forecast period. In the United States specifically, the market is expected to grow from $1.32B in 2025 to $2.15B by 2035. The growth thesis is straightforward: chronic disease prevalence is rising, surgical volumes are increasing, and hospitals face compounding pressure to reduce complications, staffing burden, and imaging costs. North America holds the largest share of the global market, driven by an aging population, elevated healthcare expenditure, and increasing investment in intelligent tube placement technology. The hospital segment commands the dominant end-user share—which is precisely the primary sales channel ENvue is targeting. Precedence Research specifically highlights that innovative companies developing app-connected pumps and advanced tube placement systems are attracting venture capital and accelerating commercialization—a direct validation of the product category FEED is building ENvue is not attempting to displace an established category leader; it is working to replace a legacy clinical practice with a modernized, real-time guidance standard that hospitals are under growing regulatory and operational pressure to adopt. The First Half of 2026 Was Busy for ENvue. Here's What You Need to Know. A lot has happened for ENvue Medical in the first half of 2026. Here are the developments that matter most. The clinical data is now on record. In June, an independent study published in Critical Care Nurse documented what the ENvue Navigation Platform delivered across 531 consecutive feeding tube placements at Inova Health System: zero tubes placed in the lungs, a 67% drop in ventilator-associated pneumonia, a dramatic increase in bedside post-pyloric feeding access that previously required interventional radiology, and over $1.5M in annual cost savings per health system. That is peer-reviewed, independently verified clinical evidence—the kind hospitals require before committing to a new standard of care. AI has entered the platform. Also in June, ENvue launched Ask Oscar™, an AI-powered training tool that allows nurses and dietitians to learn the system independently—without needing an on-site specialist. It also lays the groundwork for ENvue Drive, the company's robotic-assisted feeding tube navigation system currently in development. Existing hospital relationships are expanding. In June, ENvue deployed into the burn ICU of a major U.S. academic health network—a second unit within the same hospital system. When a hospital that already uses the platform begins adopting it in additional departments, that is a strong sign the technology is working and clinicians trust it. Long-term contracts are being signed. In May, ENvue locked in a three-year purchasing agreement renewal with a GPO that serves one of the largest health systems in the country—over 90 hospitals. Shortly after, a separate 12-hospital network in Virginia and North Carolina renewed for three years and formally designated the ENvue Navigation Platform as its standard of care for bedside feeding tube placement through 2028. The patent portfolio is growing. The USPTO granted ENvue a Notice of Allowance in February 2026 for a next-generation feeding tube that combines electromagnetic navigation with a built-in camera—giving clinicians both real-time positioning and direct internal visualization in a single device. A second Notice of Allowance followed in May covering ultrasound-enhanced dr-ug delivery technology, adding another layer to the company's IP position. 7 Reasons Why FEED is Topping Our Watchlist This Morning—Thursday, July 9, 2026… 1. Small Float: With fewer than 6.1M shares listed as available to the public, FEED’s small float could witness the potential for big moves if demand begins to shift. 2. AI Expansion: FEED recently introduced Ask Oscar™, an AI-powered training platform designed to help clinicians learn the ENvue Navigation System independently while supporting the company's platform ecosystem. 3. Clinical Evidence: FEED is backed by an independent peer-reviewed study documenting zero lung placements across 531 consecutive procedures, a 67% reduction in ventilator-associated pneumonia, and more than $1.5M in annual cost avoidance within the health system studied. 4. Hospital Adoption: FEED now has 40+ U.S. hospitals using its platform, along with recent multi-year purchasing agreement renewals and expanding deployments within existing health systems. 5. Recurring Revenue: FEED's platform pairs installed navigation systems with proprietary single-use feeding tubes, creating recurring revenue tied to ongoing clinical utilization. 6. Modernizing Care: FEED is developing technology aimed at replacing an 85-year-old bedside feeding tube placement approach with real-time electromagnetic navigation that provides continuous visualization during placement. 7. Growing Market: FEED operates in an enteral feeding devices market that Precedence Research projects will expand from approximately $4.96B in 2025 to $8.02B by 2035, supported by increasing demand for advanced tube placement technologies. Get FEED Up On The Screen While It’s Still Early… Several important pieces are now beginning to come together for FEED. A relatively small float, expanding hospital adoption, an AI-powered training platform, independently published clinical evidence, a platform designed to generate recurring revenue through ongoing clinical use, and a technology focused on modernizing an 85-year-old clinical practice all contribute to why this company has climbed onto our watchlist. Add in a healthcare market projected to continue expanding over the coming years, and it's easy to understand why FEED is a company we'll be following closely. We have all eyes on FEED this morning. Take a look at FEED while it’s still early. Sincerely, Jeff Ackerman Managing Editor Stock News Trends StockNewsTrends.com (“StockNewsTrends” or “SNT” ) is owned by TD Media LLC, a single member limited liability company. Data is provided from third-party sources and SNT is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile SNT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors. ENvue Medical, Inc. (FEED:US) previously changed their company name and symbols from NanoVibronix Inc. (NAOV:US) Pursuant to an agreement between TD Media LLC and JRZ Capital LLC, TD Media LLC has been hired for a period beginning on 07/09/2026 and ending on 07/09/2026 to publicly disseminate information about (FEED:US) via digital communications. Under this agreement, JRZ Capital LLC has paid TD Media LLC one hundred thousand USD (“Funds”). To date, including under the previously described agreement, TD Media LLC has been paid three hundred ninety thousand USD (“Funds”). These Funds were part of the one hundred thousand USD funds that TD Media LLC received from a third party named JRZ Capital LLC who did receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices. Neither TD Media LLC and their member own shares of (FEED:US). Please see important disclosure information here: https://lifewatermedia.com/disclosure/feed-8NLQF/#details

TD Media LLC | 5826 New Territory Blvd., Unit #2144, Sugar Land, TX 77479 Unsubscribe Update Profile | About our service provider Sent by jeff@stocknewstrends.com

All Eyes Are On (NYSE: SRFM) This Morning After Palantir Just Disclosed an 8.2M Share Position

Any content you receive is for information purposes only. Always conduct your own research. Sponsored Thursday’s Spotlight: SRFM Beat Its Q1 EBITDA Guidance and Is Now Selling Its Enterprise Aviation Software to One of the Biggest Names in Private Aviation. Don’t Miss Our Next Update—Get Real-Time Alerts Sent Directly To Your Phone. Up To 10X Faster Than Email. Consider Starting Your Own Research On SRFM... [ Company Website ] | [ Corporate News Portal ] Here’s Why It Is Topping My Watchlist This Week. July 9, 2026 Dear Reader, Several developments have already come together for this company, and they continue pointing in the same direction. An expanded technology partnership, strengthening commercial momentum, and improving operating results all contribute to why it remains near the top of our watchlist this morning. If you missed our earlier report, now is a good time to catch up. Air mobility is putting together one of its strongest stretches of the year, and one NYSE-listed company is sitting right in the middle of it. On June 29, Palantir Technologies (NASDAQ: PLTR) announced an expansion of its partnership with Surf Air Mobility (NYSE: SRFM), committing additional engineering and go-to-market resources to accelerate the commercial rollout of OperatorOS, OwnerOS, and SurfOS Enterprise Solutions. The expansion builds directly on the successful commercial launch of BrokerOS and the recent Wheels Up agreement valued at up to $12M. Palantir's Global Head of Commercial said the companies see a clear path to build and define the central operating system for the future of aviation and air mobility. And Palantir just put real capital behind that conviction. A Schedule 13G filed June 24 shows Palantir now holds 8,248,989 Surf Air Mobility common shares, a 7.4% stake SurfOS, powered by Palantir. BrokerOS is commercially live That commitment lands on top of a run of potential catalysts. On June 25, Surf Air Mobility announced Wheels Up (NYSE: UP), one of the world's largest private aviation companies, as the launch customer for Enterprise BrokerOS. The two-year firm agreement includes $8M in subscription fees, with an option for a third year, for a total potential software revenue of up to $12M. SRFM is also strengthening its balance sheet. On July 1, Surf Air Mobility announced two debt financing transactions designed to reduce future shareholder dilution, refinancing a roughly $46.9M senior secured convertible note into a new $16.9M convertible note due 2027 and a new $30M non-convertible senior secured term note due 2028. CEO Deanna White noted that the company's recent business development announcements with Palantir, Wheels Up, and BETA Technologies all reflect progress across its core objectives. On the electrification side, BETA Technologies launched an electric aircraft demonstration program in Hawaiʻi on June 26, with Hawaiian Airlines supporting evaluation activities. The program is testing regional cargo and passenger operations ahead of the company's plan to become the first Part 135 operator to commercialize electric passenger flights for scheduled service and on-demand charter. Then in May, Surf Air Mobility reported its first quarter 2026 financial results and outperformed its own Adjusted EBITDA guidance. Revenue came in at $25.6M, at the high end of the guidance range and up 9% year over year. The Adjusted EBITDA loss narrowed to $12.3M, better than the guided range of a $15.5 to $13.5M loss. And the company improved its full year 2026 Adjusted EBITDA loss guidance by approximately 40%, from a prior range of $50 to $40M loss to a new range of $30 to $25M loss, while reaffirming revenue guidance of $128 to $138M, a 20% to 30% growth over 2025. The standout was the private charter business. Surf On Demand revenue jumped 77% year over year to $10.1M, its highest revenue and highest gross margin quarter since inception, with revenue per flight up 38%. That is the BrokerOS and Powered by Surf On Demand engine starting to show up directly in the numbers. Then came the milestone that caught our attention. On May 13, Surf Air Mobility joined the FAA-sponsored Center for Advanced Aviation Technologies (CAAT) Consortium, becoming the first Part 135 passenger operator to do so. The CAAT is a national initiative between the Texas A&M University System and the Federal Aviation Administration, built to bring government, academia, and industry together to integrate electric aircraft, autonomous systems, and advanced aviation technology into the national airspace. Membership gives SRFM potential access to FAA-funded research programs, eligibility to respond to task orders reserved for consortium members, and a seat in the working groups shaping future solicitations. Deanna White, the company's CEO, put it plainly: “We are pleased with our first quarter Adjusted EBITDA results, which exceeded our expectations. The progress we’ve made across our business has positioned us to improve our annual 2026 Adjusted EBITDA guidance by 40% while maintaining our full year revenue guidance. The efficiencies gained within our core businesses in the first quarter are a clear indication of the value that SurfOS and our partnership with Palantir delivers.” Zoom out, and the runway is enormous. The regional air mobility market is projected to expand to $75 to $115B globally by 2035, and the global eVTOL aircraft market is forecast to grow from over $5B in 2026 to more than $216B by 2035, an increase of more than 4,000%. Keep reading to learn more about Surf Air Mobility. The BETA ALIA in Surf Air livery. SRFM holds a firm order for 25 all-electric aircraft, with options for up to 75 more. Surf Air Mobility Inc. SRFM Surf Air Mobility is a Los Angeles-based air mobility platform and one of the largest commuter airlines in the United States by scheduled departures. In the first quarter of 2026 alone, the company flew 65,376 scheduled passengers across 12,503 scheduled departures and 11,061 scheduled flight hours, while its Surf On Demand private charter arm completed 832 flights, all at a 96% controllable completion factor. Beyond flight operations, SRFM is building the digital backbone of air mobility, an AI-enabled operating system designed to transform how the industry manages everything from scheduling to compliance to booking. And this platform, powered by Palantir Technologies' (NASDAQ: PLTR) Foundry and AIP, is not just for internal use. The company is commercializing its SurfOS software across the broader market, with BrokerOS commercially live since December 2025 and 29 brokers already enrolled, and Palantir now dedicating additional resources to accelerate OperatorOS, OwnerOS, and SurfOS Enterprise Solutions. Latest Development: A Deepened Palantir Commitment, a Balance Sheet Cleanup, and Real Operating Proof Palantir Doubles Down: On June 29, Palantir announced an expanded partnership with SRFM, committing additional engineering and go-to-market resources to accelerate commercialization of OperatorOS, OwnerOS, and SurfOS Enterprise Solutions, on top of the already-live BrokerOS and the Wheels Up enterprise deal. Balance Sheet Strength: On July 1, SRFM refinanced a roughly $46.9M convertible note into a smaller $16.9M convertible note and a new $30M term note, a move designed to reduce future shareholder dilution. Financial Proof, Ahead of Plan: First quarter revenue of $25.6M landed at the high end of guidance, the Adjusted EBITDA loss of $12.3M beat the guided range, and full year 2026 Adjusted EBITDA guidance improved roughly 40%. The On Demand charter business delivered its best quarter ever, up 77% year over year. Government and Safety Validation: SRFM became the first Part 135 passenger operator inside the FAA's CAAT Consortium. In the same quarter, its airline operations completed a Safety Management System a full year ahead of the FAA's May 2027 mandate, and Surf On Demand earned ARGUS Certified Charter Broker status. The Electrification Potential Catalyst Is Real: Through a strategic partnership with BETA Technologies, SRFM holds a firm order for 25 all-electric ALIA aircraft with options for up to 75 more, and it eliminated up to $100M in planned capital expenditure from its prior electrification program along the way. A new demonstration program with Hawaiian Airlines is now underway in Hawaiʻi, where Mokulele already operates the largest commuter airline in the state. On the expanded Palantir commitment, Palantir was direct: private aviation and air mobility are large, growing markets that have historically relied on fragmented systems and manual processes. With Foundry and AIP powering SurfOS, Palantir said it sees a path to help build and define the central operating system for the future of aviation and air mobility, while its expanded commitment reflects its conviction in Surf Air Mobility and the road ahead. See the full first quarter 2026 results here. Consider Starting Your Own Research On SRFM... [ Company Website ] | [ Corporate News Portal ] 7 Reasons Why Surf Air Mobility Inc. (NYSE: SRFM) Is Back at the Top of My Watchlist Today—Thursday, July 9, 2026… 1. Palantir Just Deepened Its Commitment: On June 29, Palantir announced an expanded partnership with SRFM, committing additional engineering and go-to-market resources to accelerate commercialization of OperatorOS, OwnerOS, and SurfOS Enterprise Solutions, building directly on the live BrokerOS platform and the Wheels Up enterprise deal. Palantir owns a 7.4% stake in SRFM as of their 13G filing in June. 2. SRFM Just Beat Guidance and Raised Its EBITDA Outlook: First quarter Adjusted EBITDA loss of $12.3M came in better than the guided $15.5 to $13.5M range, and full year 2026 Adjusted EBITDA guidance improved by roughly 40% to a loss of $30 to $25M, with revenue guidance reaffirmed at $128 to $138M. 3. SurfOS Is Live, Producing Real Numbers, and Just Landed a Major Enterprise Customer: BrokerOS launched commercially in December 2025 with early internal results showing 32% more bookings for top brokers, 57% faster quote-to-close, and 40% more payments processed on-platform in Q1 2026 versus Q1 2025. Now it has its first enterprise deployment: Wheels Up (NYSE: UP), one of the world's largest private aviation companies, signed on as launch customer for Enterprise BrokerOS under a deal worth up to $12M in software subscription fees. OperatorOS is still scheduled for commercial launch in the second half of 2026. 4. Management Is Cleaning Up the Balance Sheet: On July 1, SRFM refinanced its convertible note structure, cutting the convertible portion from roughly $46.9M to $16.9M and adding a $30M term note, a move explicitly designed to reduce future shareholder dilution. 5. Management Bought Alongside Institutions: In April, co-founders, officers, and directors purchased roughly $5.3M worth of shares as part of a $30M raise structured to limit dilution, $15M of it in non-dilutive aircraft-backed credit. 6. The Palantir Moat Is Structural: SRFM holds an exclusive five-year agreement with Palantir Technologies for the configuration and sale of Foundry and AIP-powered software to the Part 135 regional aviation market. Palantir is one of the largest non-in-sider shareholders, and Shawn Pelsinger, the former Palantir executive who helped architect Skywise with Airbus, joined the board in October 2025 and was just elected Chairman, effective July 24, 2026. 7. An Electrification Potential Catalyst With a Massive Market Behind It: The BETA partnership puts up to 100 all-electric aircraft within reach and removed up to $100M in planned capex and a new demonstration program with Hawaiian Airlines is now underway in Hawaiʻi. Meanwhile the regional air mobility market is projected to reach $75 to $115B by 2035. Coverage is building too, with HC Wainwright at “Bullish” and Stonegate noting SRFM is roughly around 1.3x forward EV/Revenue versus a peer average near 2.4x. Consider Starting Your Own Research On SRFM... [ Company Website ] | [ Corporate News Portal ] The expanded Palantir commitment, layered on top of the Q1 results, the balance sheet cleanup, and the electrification roadmap, ties the whole story together. A deepened partnership with one of the biggest names in enterprise software. Revenue at the high end of guidance. An Adjusted EBITDA beat. Full year profitability guidance improved by roughly 40%. A charter business growing 77% year over year. And the first Part 135 passenger operator seated inside an FAA advanced aviation program. Add in the exclusive Palantir partnership powering SurfOS, a former Palantir executive stepping up as Chairman of the Board, all-electric BETA aircraft on the roadmap, and fresh coverage from HC Wainwright and Stonegate, and it becomes clear why this company keeps coming back into focus for me. Zooming out, the Advanced Air Mobility backdrop keeps expanding. Forecasts put the regional air mobility market at $75 to $115B by 2035 and the eVTOL market at roughly $216B by the same year. We have all eyes on SRFM this morning—Thursday, July 9. 2026. And as always, please remember to do your own research. Alex Ramsay Co-Founder & Managing Editor Krypton Street Newsletter KryptonStreet.com (“KryptonStreet” or “KS” ) is owned by Media 1717 LLC, a single member limited liability company. Data is provided from third-party sources and KS is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile KS brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors. Pursuant to an agreement between Media 1717 LLC and TD Media LLC, Media 1717 LLC has been hired for a period beginning on 07/09/2026 and ending on 07/09/2026 to publicly disseminate information about (SRFM:US) via digital communications. Under this agreement, TD Media LLC has paid Media 1717 LLC seven thousand five hundred USD (“Funds”). To date, including under the previously described agreement, Media 1717 LLC has been paid fifty three thousand USD (“Funds”). These Funds were part of the fifteen thousand USD funds that TD Media LLC received from a third party named LFG Equities Corp. who did not receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices. Neither Media 1717 LLC, TD Media LLC and their member own shares of (SRFM:US). Please see important disclosure information here: https://kryptonstreet.com/disclosure/srfm-3QKzJ/#details

Media 1717 LLC | 6586 W Atlantic Ave, Unit #2086, Delray Beach, FL 33446 Unsubscribe Update Profile | About our service provider Sent by alex@kryptonstreet.com

Dawn dish soap can ruin these surfaces

Never buy disinfectant wipes again!

If you are having trouble viewing this email, click here.

If these articles aren't built for you, you can unsubscribe here! Never clean these 6 things with Dawn dish soap Read Full Article >>> Stop buying disinfectant wipes—make these reusable ones instead  Read Full Article >>> In case you missed it: You should be putting black pepper in your garden—here's why Read Full Article >>> Why your house is so humid, how to fix it, and the damage to look out for Read Full Article >>> Spotting these signs early could save you thousands in repairs Read Full Article >>> These common lawn care mistakes are ruining your grass Read Full Article >>> Stop your cat from scratching your couch with THIS Read Full Article >>> This marketing was sent by ManMadeDIY on behalf of Paxa Media

 

 

This email was sent to lepobook@gmail.com by hello@manmadediy.com Paxa Media, 7040 Avenida Encinas STE 104, Carlsbad, CA 92011, United States   1-Click Unsubscribe | Edit Profile | Manage Subscriptions | Report Spam